These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 15924360

  • 1. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
    Kieffer-Renaux V, Viguier D, Raquin MA, Laurent-Vannier A, Habrand JL, Dellatolas G, Kalifa C, Hartmann O, Grill J.
    Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
    [Abstract] [Full Text] [Related]

  • 2. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
    Grill J, Viguier D, Kieffer V, Bulteau C, Sainte-Rose C, Hartmann O, Kalifa C, Dellatolas G.
    J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
    [Abstract] [Full Text] [Related]

  • 3. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P, Mulhern RK, Regine WF, Rivera GK, Kun LE.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):561-6. PubMed ID: 7852120
    [Abstract] [Full Text] [Related]

  • 4. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors.
    Puget S, Boddaert N, Viguier D, Kieffer V, Bulteau C, Garnett M, Callu D, Sainte-Rose C, Kalifa C, Dellatolas G, Grill J.
    Cancer; 2009 Mar 15; 115(6):1338-47. PubMed ID: 19195041
    [Abstract] [Full Text] [Related]

  • 5. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy.
    Merchant TE, Lee H, Zhu J, Xiong X, Wheeler G, Phipps S, Boop FA, Sanford RA.
    J Neurosurg; 2004 Nov 15; 101(2 Suppl):159-68. PubMed ID: 15835103
    [Abstract] [Full Text] [Related]

  • 6. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.
    J Clin Oncol; 2005 Aug 20; 23(24):5511-9. PubMed ID: 16110011
    [Abstract] [Full Text] [Related]

  • 7. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart S.
    J Clin Oncol; 2009 Apr 10; 27(11):1879-83. PubMed ID: 19273707
    [Abstract] [Full Text] [Related]

  • 8. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P, Freeman C, Bernstein ML, Lawrence S, Rodd C.
    Arch Pediatr Adolesc Med; 2004 May 10; 158(5):491-6. PubMed ID: 15123484
    [Abstract] [Full Text] [Related]

  • 9. Change in neurocognitive functioning after treatment with cranial radiation in childhood.
    Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ.
    J Clin Oncol; 2004 Feb 15; 22(4):706-13. PubMed ID: 14966095
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):974-9. PubMed ID: 19864079
    [Abstract] [Full Text] [Related]

  • 11. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG, Barker JL, Ellenbogen RG, Geyer JR.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1161-4. PubMed ID: 15001259
    [Abstract] [Full Text] [Related]

  • 12. Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy.
    Radcliffe J, Packer RJ, Atkins TE, Bunin GR, Schut L, Goldwein JW, Sutton LN.
    Ann Neurol; 1992 Oct 15; 32(4):551-4. PubMed ID: 1456739
    [Abstract] [Full Text] [Related]

  • 13. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
    Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, Dellatolas G, Raquin MA, Jambaqué I, Kalifa C.
    Int J Radiat Oncol Biol Phys; 1999 Aug 01; 45(1):137-45. PubMed ID: 10477017
    [Abstract] [Full Text] [Related]

  • 14. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.
    Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E.
    J Clin Oncol; 2005 Apr 01; 23(10):2256-63. PubMed ID: 15800316
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychologic function in children with brain tumors: II. Serial studies of intellect and time after treatment.
    Kun LE, Mulhern RK.
    Am J Clin Oncol; 1983 Dec 01; 6(6):651-6. PubMed ID: 6637877
    [Abstract] [Full Text] [Related]

  • 16. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM.
    J Clin Oncol; 2001 Aug 01; 19(15):3470-6. PubMed ID: 11481352
    [Abstract] [Full Text] [Related]

  • 17. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study.
    Nanduri VR, Lillywhite L, Chapman C, Parry L, Pritchard J, Vargha-Khadem F.
    J Clin Oncol; 2003 Aug 01; 21(15):2961-7. PubMed ID: 12885816
    [Abstract] [Full Text] [Related]

  • 18. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.
    Sands SA, Oberg JA, Gardner SL, Whiteley JA, Glade-Bender JL, Finlay JL.
    Pediatr Blood Cancer; 2010 Mar 01; 54(3):429-36. PubMed ID: 20052775
    [Abstract] [Full Text] [Related]

  • 19. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, Swisher C, Meier P, Remington J, Jalbrzikowski J, McLeod R, Kipp M, Rabiah P, Chamot D, Estes R, Cezar S, Mack D, Pfiffner L, Stein M, Danis B, Patel D, Hopkins J, Holfels E, Stein L, Withers S, Cameron A, Perkins J, Heydemann P.
    Pediatrics; 2006 Aug 01; 118(2):e379-90. PubMed ID: 16864640
    [Abstract] [Full Text] [Related]

  • 20. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J, Jawad AF.
    Pediatrics; 2005 Jul 01; 116(1):117-22. PubMed ID: 15995041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.